The abstract is read at the publisher; the summary is JClub's.
PESPION-enhanced magnetic particle imaging detects MSR1-linked macrophage phagocytosis in vulnerable ApoE-/- mouse carotid plaques, with signals reduced by MSR1 inhibition.
- Why it matters: New atherosclerosis therapies need noninvasive early readouts of plaque vulnerability and treatment response, rather than waiting for slower imaging endpoints.
- What they did: Human carotid plaque transcriptomics and immunofluorescence identified MSR1 as a vulnerability-associated phagocytosis marker; PESPION was compared with Vivotrax and ferumoxytol, then tested in cast-induced vulnerable plaques in ApoE-/- mice treated for 10 weeks with inclisiran or empagliflozin.
- The result: PESPION-enhanced MPI sensitively detected vulnerable plaques, correlated with plaque area and macrophage infiltration, predicted the vulnerability index, and detected therapeutic response at 4 weeks versus T2*-weighted MRI at 10 weeks.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.